Mitochondrial respiratory chain dysfunction in muscle from patients with amyotrophic lateral sclerosis.

Archives of Neurology
Veronica CrugnolaM Moggio

Abstract

Amyotrophic lateral sclerosis (ALS) is a major cause of neurological disability and its pathogenesis remains elusive despite a multitude of studies. Although defects of the mitochondrial respiratory chain have been described in several ALS patients, their pathogenic significance is unclear. To review systematically the muscle biopsy specimens from patients with typical sporadic ALS to search for possible mitochondrial oxidative impairment. Retrospective histochemical, biochemical, and molecular studies of muscle specimens. Tertiary care university. Subjects Fifty patients with typical sporadic ALS (mean age, 55 years). Main Outcome Measure Number of patients showing a clear muscle mitochondrial dysfunction assessed through histochemical and biochemical muscle analysis. Histochemical data showed cytochrome c oxidase (COX)-negative fibers in 46% patients. Based on COX histochemical activity, patients fell into 4 groups: 27 had normal COX activity; and 8 had mild (2-4 COX-negative fibers of 100 fibers), 8 had moderate (5-10 COX-negative fibers of 100), and 7 had severe (>10 COX-negative fibers of 100) COX deficiency. Spectrophotometric measurement of respiratory chain activities showed that 3 patients with severe histochemical COX...Continue Reading

Citations

Dec 25, 2013·Oxidative Medicine and Cellular Longevity·Akshay AnandPawan Kumar Gupta
Nov 17, 2010·Current Neurology and Neuroscience Reports·Rebecca TraubLewis P Rowland
May 24, 2011·Journal of Neurology·Massimiliano FilostoAlessandro Padovani
May 23, 2014·Journal of Proteomics·Kristin ElfKonstantin Artemenko
Aug 3, 2011·Expert Opinion on Emerging Drugs·Ali Aamer Habib, Hiroshi Mitsumoto
Apr 9, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Pierre-François PradatGillian Butler-Browne
Aug 13, 2011·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·Alessandro MezzaniPantaleo Giannuzzi
Dec 18, 2013·Seminars in Pediatric Neurology·Christos D KatsetosJoseph J Melvin
Nov 10, 2012·Physical Medicine and Rehabilitation Clinics of North America·Marlia M BraunNanette C Joyce
Jan 18, 2011·Toxicology and Applied Pharmacology·Richelle A HemendingerBenjamin Rix Brooks
Jul 23, 2015·Journal of the Neurological Sciences·S T NgoP A McCombe
Oct 24, 2013·British Journal of Pharmacology·H Muyderman, T Chen
Jan 19, 2016·Brain Pathology·Jean-Philippe LoefflerJose-Luis Gonzalez De Aguilar
Jan 19, 2016·Brain Pathology·Mario SabatelliSerena Lattante
May 15, 2015·Acta Neuropathologica Communications·Citlalli Netzahualcoyotzi, Ricardo Tapia
Sep 24, 2013·Mutation Research. Reviews in Mutation Research·Varinderpal S Dhillon, Michael Fenech
Sep 24, 2015·Pharmacological Reports : PR·Touqeer AhmedSeyed Mohammad Nabavi
Apr 22, 2015·Journal of Neurology·Johannes K EhingerEskil Elmér
Sep 18, 2015·Frontiers in Cellular Neuroscience·Francesco TafuriStefania Corti
Jan 13, 2015·Brain : a Journal of Neurology·Dario RonchiGiacomo Pietro Comi
Jan 13, 2015·Brain : a Journal of Neurology·Sylvie BannwarthVéronique Paquis-Flucklinger
Sep 15, 2012·Neurobiology of Disease·Aaron P RussellTakayuki Akimoto
Sep 11, 2014·Drug Discovery Today·Yongjin ZhuXin Wang
Aug 11, 2011·Progress in Neurobiology·Mauro Cozzolino, Maria Teresa Carrì
Jul 28, 2015·Translational Neurodegeneration·Satoshi Yamashita, Yukio Ando
Mar 21, 2015·Human Molecular Genetics·Mattéa J FinelliKay E Davies
Apr 10, 2013·Free Radical Biology & Medicine·Rajnish K Chaturvedi, M Flint Beal
Jun 26, 2013·Free Radical Biology & Medicine·Emanuele D'AmicoHiroshi Mitsumoto
Mar 19, 2014·Journal of the Neurological Sciences·S T NgoP A McCombe
Apr 20, 2016·ACS Chemical Neuroscience·Luz Diana Santa-CruzRicardo Tapia
May 7, 2016·Acta Neuropathologica Communications·Elisa OnestoAntonia Ratti
May 24, 2016·Trends in Molecular Medicine·Liyana AhmadVanessa Sancho-Shimizu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating genetic alterations in this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.